DOUG RICHARDSON — Lobbyist Profile | Poliscope

DOUG RICHARDSON

Filings

Clients

Firms

Years active

2008–2008

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)	1	2008

Lobbying firms

Firm	Filings	Years
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)	1	2008

Bills explicitly cited in this lobbyist’s assigned issues (1)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 2676

Access to Cancer Clinical Trials Act of 2007

Client: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) · Firm: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

Open original LDA filing ↗

Cited source text

BUD - FY 2009 Budget HHS (NIH-NCI-CDC) Appropriations MED - Medicare - Cancer Coverage Issues H.R. 2676 - Access to Clinical Trials Act

Original LDA source filings (1)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) via BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

2008 · first_quarter · Q1

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

BUD - FY 2009 Budget HHS (NIH-NCI-CDC) Appropriations MED - Medicare - Cancer Coverage Issues H.R. 2676 - Access to Clinical Trials Act

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Source: Senate LDA